Enova International, Inc. ENVA ← Back to all reports

Enova International, Inc.

ENVA · Financials
B ★★★ Hold
Aug 15, 2026 · Score 81 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $261.92
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $230.00 ($220.00–$240.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $269.62
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+2.9%

Type A - Enova International, Inc. (ENVA) 20260815 Stock Analysis

📅 Enova Key Upcoming Events

🏢 Step 1: Enova Company Overview & Business Model

Q1-A1. What is Enova?

Q1-A2. How Does Enova Make Money?

Q1-A3. Enova’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Enova’s Competitors?

Q1-A5. Enova Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Enova’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Enova Have a Durable Economic Moat?

Q2-A2. Is Enova’s Growth Sustainable?

Q2-A3. How Does Enova Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Enova Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Enova? (Margins & ROIC)

Q3-A3. What Drives Enova’s Returns? (ROIC Breakdown)

Q3-A4. Are Enova’s Earnings High Quality?

Q3-A5. Is Enova’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Enova Forensic Accounting & Dilution Review

Q4-A1. Does Enova Have Accounting Red Flags?

Q4-A2. Is Enova Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Enova’s Cash Flow?

Q4-A4. Is Enova Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Enova Management & Shareholder Alignment

Q5-A1. Can You Trust Enova’s Management? (Guidance Track Record)

Q5-A2. What Are Enova Insiders Doing?

Q5-A3. Is Enova’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Enova Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Enova Guidance

Q6-A2. What Is Enova’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Enova Catalysts & Price Triggers

Q7-A1. What Could Move Enova Stock? (Top 3 Catalysts)

Q7-A2. Enova’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Enova Fairly Valued? Valuation Analysis

Q8-A1. Enova’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Enova vs Peers: Valuation Comparison

Q8-A3. Is Enova Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Enova? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Enova? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Enova’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Enova? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Enova?

Q9-A2. How Sensitive Is Enova to the Economy?

Q9-A3. Enova Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Enova Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Enova? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Enova’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Enova’s Reliance on Subprime Lending Its Biggest Weakness?

Q2: Can Enova’s 17.69x Trailing P/E Be Justified by the Grasshopper Bank Acquisition?

Q3: Will Political and Regulatory Pushback Derail the Grasshopper Deal?

Q4: How Resilient is Enova’s OnDeck Small Business Segment in a Macro Downturn?

Q5: Does Enova’s Colossus Machine Learning Platform Provide a Genuine Economic Moat?

Q6: How Does the Shifting Cost of Funds Impact Enova’s Net Revenue Margins?

Q7: Are the Recent Heavy Insider Sales by Executive Chairman David Fisher a Red Flag?

Q8: Can Enova Maintain Its Target 30-35% Adjusted EPS Growth Trajectory?

Q9: How Vulnerable is the CashNetUSA Segment to Emerging State-Level Usury Caps?

Q10: What Happens if the OCC and Federal Reserve Deny the National Bank Charter?